Search

everythinglearnresearchcommunity

for

Search:↓

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

The VEGF +405G allele may increase the risk of PCOS in South Indian women.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

NBCCS and BFHS might be the same syndrome, helping better identify and manage cases.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

The article concludes that global standardization in PCOS research is crucial for accurate diagnosis and understanding of the condition.

Oxidative stress, not insulin resistance, is significantly related to free androgen index in PCOS.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Low intensity ultrasound may reduce side effects of chemotherapy drugs like paclitaxel.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

L-cystine and vitamin B6 at high doses prevented hair loss in mice treated with a chemotherapy drug.

Lipid–polymer hybrid nanoparticles can improve genome editing delivery and outcomes.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

PCOS is a major cause of infertility and requires personalized treatment.

Gonadal biopsy is the best method to diagnose gonadal dysgenesis.

Finasteride helps reduce heart enlargement in heart failure patients.

A boy with a rare form of early puberty caused by a new gene mutation responded well to treatment aimed at reducing testosterone and preserving adult height.

Pretreatment methods can enhance bioactive content in lactogenic herbs.

Panniculitis in dermatomyositis is rare, more common in women, and may persist despite treatment.